Page last updated: 2024-09-05

deferasirox and ferric oxide, saccharated

deferasirox has been researched along with ferric oxide, saccharated in 1 studies

Compound Research Comparison

Studies
(deferasirox)
Trials
(deferasirox)
Recent Studies (post-2010)
(deferasirox)
Studies
(ferric oxide, saccharated)
Trials
(ferric oxide, saccharated)
Recent Studies (post-2010) (ferric oxide, saccharated)
832136572690193341

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toyokuni, S1

Reviews

1 review(s) available for deferasirox and ferric oxide, saccharated

ArticleYear
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.
    Redox report : communications in free radical research, 2014, Volume: 19, Issue:1

    Topics: Adsorption; Animals; Asbestos; Asbestosis; Benzoates; Carcinogens, Environmental; Carcinoma, Renal Cell; Cell Transformation, Neoplastic; Comparative Genomic Hybridization; Deferasirox; Ferric Compounds; Ferric Oxide, Saccharated; Genes, p16; Glucaric Acid; Humans; Iron Chelating Agents; Iron Overload; Japan; Kidney Neoplasms; Male; Mesothelioma; Mineral Fibers; Peritoneal Neoplasms; Phlebotomy; Pleural Neoplasms; Rats; Triazoles

2014